These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 796524)

  • 1. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF; Beischer W; Thum C; Clemens AH
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin treatment during diabetic coma with an artificial endocrine pancreas.
    Pfeiffer EF; Kerner W; Beischer W; Klier M
    Horm Metab Res Suppl; 1979; (8):150-5. PubMed ID: 43829
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physiopathology of diabetes and the artificial endocrine pancreas].
    Albisser AM; Leibel BS; Marliss EB; Zinman B; Botz CK; Zingg W; Murray FT; Denoga A
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():259-68. PubMed ID: 796523
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: Artificial beta-cell in experimental and clinical medicine].
    Pfeiffer EF; Thum C; Beischer W; Clemens AH
    MMW Munch Med Wochenschr; 1975 May; 117(20):849. PubMed ID: 805997
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P
    Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065
    [No Abstract]   [Full Text] [Related]  

  • 8. The rationale for the use of drugs in the treatment of diabetes mellitus.
    Kryston LJ; Shaw RA
    Semin Drug Treat; 1974; 3(4):365-75. PubMed ID: 4207077
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The artificial endocrine pancreas in clinical research.
    Pfeiffer EF; Beishcher W; Kerner W
    Horm Metab Res; 1977; Suppl 7():95-114. PubMed ID: 406185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
    Rodríguez García MA; Gutiérrez López MA; Durán García S
    Med Clin (Barc); 1988 Jun; 91(3):81-2. PubMed ID: 3050312
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of an artificial beta cell in surgery.
    Horwitz DL; Schwartz SS
    Horm Metab Res Suppl; 1979; (8):156-8. PubMed ID: 395072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Insulin treatment of decompensated diabetes mellitus with a new artificial endocrine pancreas (author's transl)].
    Kerner W; Beischer W; Tamás G; Raptis S; Pfeiffer EF
    Dtsch Med Wochenschr; 1977 Oct; 102(42):1500-5. PubMed ID: 334502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF; Thum C; Clemens AH
    Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
    [No Abstract]   [Full Text] [Related]  

  • 15. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma insulin in normal children and in diabetic children treated with intramuscular injections of insulin (author's transl)].
    Gouedard H; Vicq D
    Ann Pediatr (Paris); 1981 Sep; 28(7):475-80. PubMed ID: 7025727
    [No Abstract]   [Full Text] [Related]  

  • 17. Substitution of islet cell function by mechanical device: extracorporeal artificial pancreas.
    Pfeiffer EF; Kerner W; Beischer W
    Adv Exp Med Biol; 1979; 119():501-8. PubMed ID: 386732
    [No Abstract]   [Full Text] [Related]  

  • 18. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J; Selam JL; Pham TC; Orsetti A
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin biosynthesis and C-peptide. Practical applications from basic research.
    Sperling MA
    Am J Dis Child; 1980 Dec; 134(12):1119-21. PubMed ID: 7004174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.